VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Aggregate cash dividend of $17.3 million, or approximately $0.40242 per shareNEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics …